Regional clinical and economic model of colorectal cancer screening
Open Access
- 12 September 2020
- journal article
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 7 (3), 146-159
- https://doi.org/10.17709/2409-2231-2020-7-3-15
Abstract
Purpose of the study. To evaluate the clinical and economic efficiency of colorectal cancer screening model in the Yaroslavl region. Materials and methods. To achieve this goal, we have given a clinical and economic assessment of the existing approach to the diagnosis and treatment of colon cancer. We have also developed a clinical and economic model of colorectal cancer screening strategy in the Yaroslavl region. After that, we made a comparative assessment between the strategies on such parameters as total costs, efficiency, and CER coefficient. Results. The strategy for the absence of colorectal cancer screening has a cost-effectiveness rate equal to 246 712 rubles (3820$)/LYG, with the value of added years of life in 2.9 years. According to our calculations, the implementation of the program of screening of CRC based on fecal occult blood immunochemical method, followed by the implementation of colonoscopy in the case of a positive result, will require an increase in funding for patients with colon cancer by 6.9% per year. At the same time, by changing the structure of morbidity and increasing the part of early forms in the implementation of the screening program, an increase in the estimated life expectancy of patients will be achieved, which is consistent with the long-term results of programs conducted in Europe and the United States. The CER for the screening strategy is 103.95 thousand rubles (2030$) / LYG. Long-term modeling shows that the introduction of screening program will reduce the incidence of CRC by 12% from the baseline by the 15th year of implementation and reduce the cost of diagnosis and treatment of colon cancer by 16.1% per year without taking into account inflation expectations. Conclusion. The introduction of a colorectal cancer-screening program at the regional level is clinically effective and cost-effective.Keywords
This publication has 26 references indexed in Scilit:
- Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2017
- Global patterns and trends in colorectal cancer incidence and mortalityGut, 2016
- Effectiveness of fecal immunochemical testing in reducing colorectal cancer mortality from the One Million Taiwanese Screening ProgramCancer, 2015
- Use of a Low Cut-Off Value for the Fecal Immunochemical Test Enables Better Detection of Proximal NeoplasiaDigestive Diseases and Sciences, 2013
- Screening for colorectal cancer with immunochemical faecal occult blood testsDigestive and Liver Disease, 2012
- Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer DeathsThe New England Journal of Medicine, 2012
- Adherence to follow‐up after a positive fecal occult blood test in an organized colorectal cancer screening program in Korea, 2004–2008Journal of Gastroenterology and Hepatology, 2011
- French colorectal cancer screening pilot programme: results of the first roundJournal of Medical Screening, 2008
- Cochrane Systematic Review of Colorectal Cancer Screening Using the Fecal Occult Blood Test (Hemoccult): An UpdateThe American Journal of Gastroenterology, 2008
- Update on the Paris Classification of Superficial Neoplastic Lesions in the Digestive TractEndoscopy, 2005